Home   >  
Neuro Signaling Pathway
  • GPCR/G Protein
∨
  >  
Histamine Receptor

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Histamine Receptor

Chemical Structure Cat. No. Product Name CAS No.
Metiamide Chemical Structure
 BCP21503 Metiamide 34839-70-8
Metiamide is a histamine H2-receptor antagonist developed from another H2 antagonist, burimamide.
Pemirolast potassium Chemical Structure
 BCP21138 Pemirolast potassium 100299-08-9
Pemirolast potassium is a potent histamine H1 antagonist and mast cell stabilizer that acts as an antiallergic agent. It has also been studied for the treatment of asthma. Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats. Pemirolast reduces cisplatin-induced kaolin intake in rats.
Quifenadine Chemical Structure
 BCP21301 Quifenadine 10447-39-9
Quifenadine is an H1-histamine receptor blocker with antiarrhythmic properties.
Immethridine dihydrobromide Chemical Structure
 BCP27655 Immethridine dihydrobromide 87976-03-2
Immethridine is a histamine agonist selective for the H3 subtype.
Dimaprit Dihydrochloride Chemical Structure
 BCP27612 Dimaprit Dihydrochloride 23256-33-9
Dimaprit Dihydrochloride is a histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.
GSK-189254 hydrochloride Chemical Structure
 BCP23443 GSK-189254 hydrochloride 945493-87-8
GSK 189254A is histamine H3 receptor antagonist for the treatment of narcolepsy. The compound may also be useful in the treatment of dementia and neuropathic pain.
Brompheniramine maleate Chemical Structure
 BCP23378 Brompheniramine maleate 980-71-2
Brompheniramine maleate is a histamine H1 receptors antagonist.
MK-0249 Chemical Structure
 BCP30795 MK-0249 1167574-41-5
MK-0249 is a histamine H3 inverse antagonist. Current antipsychotic treatments have little impact on the cognitive deficits associated with schizophrenia. It has been proposed that agents which promote histamine release may enhance cognition and, therefore, the H3 inverse agonist MK-0249 might improve cognitive deficits in patients with schizophrenia.
(R)-Meclizine Chemical Structure
 BCP28339 (R)-Meclizine 189298-48-4
Meclizine is a histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.
Tesmilifene Chemical Structure
 BCP09123 Tesmilifene 98774-23-3
Tesmilifene is a novel potentiator of chemotherapy which, when added to doxorubicin, achieved an unexpected and very large survival advantage over doxorubicin alone in a randomized trial in advanced breast cancer.
123下一页末页共 93 条记录 1 / 10 页 
0086-13720134139